What's hot
View all perspectives
What's Hot
Rheumatoid Arthritis Comorbidities
Dr. Jonathan Kay reviews rheumatoid arthritis studies presented on day at EULAR 2022. Specifically, he discusses abstracts OP0132, OP0135 and OP0138.
Watch video →
Increasing Secukinumab Dose in Ankylosing Spondylitis Nonresponders
Dr. Peter Nash discusses abstract OP0023 from EULAR 2022.
Watch video →
DMARDS, Prednisone, Pregnancy, OH MY!
Dr. Kathryn Dao discusses abstracts POS1405, POS0696 and OP0130 presented at the EULAR 2022 meeting. Watch more videos from EULAR 2022 here: https://rheumnow.com/videos.
Watch video →
Breathing New Insight into RA Interstitial Lung Disease
Dr. Jonathan Kay reviews EULAR 2022 abstracts OP0132, OP0306, and OP0307.
Watch video →
EULAR 2022 - Day 4 Faculty Panel Recap
Dr. David Liew and Dr. Jack Cush discuss day 4 of EULAR 2022. LB0001, LB0002, LB0004, and LB0006.
Watch video →
Getting to the Heart of JAK Inhibitors
Dr. Jonathan Kay reviews rheumatoid arthritis sessions and abstracts from day 3 at EULAR 2022. Abstracts reviewed: OP0266; OP0258; and OP0269.
Watch video →
EULAR 2022 - Day 3 Faculty Panel Recap
Drs. Jack Cush, Janet Pope, Aurelie Najm and Yuz Yusof discuss highlights from Day 3 of EULAR 2022.
Watch video →
Deucravacitinib at EULAR 2022
Dr. Peter Nash provides and update on the TYK2 inhibitor, Deucravacitinib with reports on: - Safety of Deucravacitinib https://bit.ly/3NtZQxe - Deucravacitinib in SLE https://bit.ly/3Mh5nG0
Watch video →
Dr. John Cush RheumNow
3 years 5 months ago
Watch: What's new in sarcoidosis?
https://t.co/GnU1FDnUhn https://t.co/H1omKPtQmn
Dr. John Cush RheumNow
3 years 5 months ago
NEJM Case - 17-Year-Old Girl with Fever and Cough and B/L lower lobe infiltrates. 3 wk hx started w/ conjunctivitis, SOB, Cough fever myalgia & knee pain. No rash. T 38.5°C, W 11.5, H/H 6.9/21, P526k, CRP 77mg/L, UA 2+ protein, neg COVID tests. https://t.co/VOiW7DIdBR https://t.co/1GWA2gAgeK
Dr. John Cush RheumNow
3 years 5 months ago
1 yr success of knee arthroplasty was drawn frm 20 studies (11 317 pts, 37 factors) suggests higher BMI was correlated w/ worse physical function. Physical function & OA severity assoc. w/ better function post-TKA https://t.co/jtDCeprUhd https://t.co/Tflw8VO5Kw
Dr. John Cush RheumNow
3 years 5 months ago
Metanalysis (48 pubs, 145 refract pts) of JAK inhibitors in myositis (DM, JDM) shows significant improvement in skin lesions, muscle weakness, and ILD. https://t.co/EUOB8XUCht https://t.co/SYeYwooUkW
What is the classic 'triad' of Still's disease? Does it affect males and females equally? What are typical lab findings? Which drugs are effective at treating Still's, and as importantly, which ones are not? What about complications? Read on for these and other FAQs regarding Still's disease.
Dr. John Cush RheumNow
3 years 5 months ago
Worldwide metanalysis of FUO shows most common infections to be Mycobacterium tuberculosis (34%), brucellosis (10%), endocarditis (7.5%), abscesses (7%), herpesvirus (CMV,EBV 7%), pneumonia (6%), URI (6%), enteric fever (5%) https://t.co/RPMb1kYEI9 https://t.co/E0lrizOUkF
RCHPediatrics RchPediatrics
3 years 5 months ago
When to think beyond infection in recurrent fever??Join us to learn a clear approach to fever and auto inflammatory disorders from expert faculty @bhat_chandrika at #cusp @rakshay_shetty @PedRheum @PeriodicFeverUK @LatikaGupta_ @DrPujaMehta1 https://t.co/roMVbBDaNK
Hector Chinoy drhectorchinoy
3 years 5 months ago
@DrPujaMehta1 @leticiakawano @docrota @DrJoPorter @drharsha_gunawa @best_rheum @jeffsparks @AshimaMakol @pedrommcmachado @KaminskiMed @KerriBerriKerri @DrPeter_George @scott_matson @LatikaGupta_ What about this one https://t.co/E6oMCFlplt
Puja Mehta 🧩 DrPujaMehta1
3 years 5 months ago
Pleased to share our review
Management of #Myositis #ILD practical guide for clinicians
#Teamwork ✍️💪
@docrota 🇺🇸 🖐️
@DrJoPorter 🫁
@drharsha_gunawa 🖐️
OpenAccess😃
https://t.co/fhCHvzXdVP
3 clinico-serological phenotypes
1⃣ anti-synthetase
2⃣ anti-MDA5
3⃣ anti-PM-Scl
/1 https://t.co/B1Qh0drSbg
Indiana University Infectious Diseases Fellowship IUIDfellowship
3 years 5 months ago
#idboardreview #meded #idmeded #IDtwitter #dermtwitter #MedTwitter Infectious differential diagnosis of rash involving palms & soles https://t.co/xXK4nYwEoi
Mithu Maheswaranathan, MD MithuRheum
3 years 5 months ago
🆕🌟CDC Guidance on COVID-19 Vaccines for Children <18 yrs who are Immunocompromised 👦👧🏾💉⬇️
Thank you Dr. Rebecca Sadun for reviewing!
#PedsTwitter #PedsRheum #Pediatrics https://t.co/eeuRKflhSO
A large cohort study of children with febrile disorders has demonstrated the diagnostic utility of Myeloid-related protein 8/14 (MRP8/14) in diagnosing systemic JIA patients (SJIA) in clinical practice.
Dr. John Cush RheumNow
3 years 5 months ago
French registry of IBD due to IL-17 inhib revealed 32 pts- risk of new IBD was low & decreased 2016 to 2019, w/ good outcome in 24/31. IBD more common w/ AS (27) vs PsO (4), IBD onse after 4 (1.5–7.5) mos; all cases w/ secukinumab https://t.co/FJAvhmzPkc https://t.co/WSIut9mAEq
A cohort study suggests that rituximab (RTX) use among patients 75 years and older with antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) is efficacious but also has a high risk of serious adverse events, likely related to associated steroid use and the advanced age of the population.
Poster Hall